Eric Lefkofsky Brings In Tempus To Aid In Cancer Treatment

Eric Lefkofsky is known for his grand success with regard to GroupOn. He could have continued to bask in that glory. But he wanted to aid in the treatment of cancer.

This realization dawned on him when his wife was detected with breast cancer. This was when he started looking for information regarding diagnosis of cancer, its treatment therapies and so on. This was when he realized that even though cancer is such a common disease today, there is little information available on it. This is why doctors are not able to take informed decisions. In the end, it impacts cancer patients and their treatments. Read News Here .

This is how Tempus was born. This is an operation system that is devised keeping the cancer patients in mind. Doctors required this in order to treat their patients. But developing something like Tempus would have required scientific steps. This is where Eric played a key role. He has years of experience in building successful businesses. These are related to aggregating vast amounts of data. This data has to be mined in order get insights that can help to advance the status of given industry.

Eric Lefkofsky made Tempus which allows partnering doctors to make use of its analytics system. This lets them learn more about their patients and formulate their treatment plans accordingly.

There are a number of health centers that are collaborating with Tempus in order to make use of it. One of these is the Abramson Cancer Center at the University of Pennsylvania. There are a number of local hospitals that have teamed up with Tempus. This includes the Lurie Comprehensive Cancer Center of the Northwestern University. Another is the Rush University Medical Center. There is a clinical trial group which is at the University of Chicago. Even this has teamed up with Tempus to make use of its data and services.

Lefkofsky is well aware that it is a long journey. There will be no quick results here. But he says that it will be an exciting journey. This is because he is getting technology to cancer and healthcare. for more .